Glancy Prongay & Murray LLP Commences Investigation on Behalf of NuVasive, Inc. Investors (NUVA)

Oct 31, 2017 03:33 pm
LOS ANGELES -- 

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of NuVasive, Inc. (“NuVasive” or the “Company”) (NASDAQ: NUVA) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the NuVasive investigation page on our website www.glancylaw.com/case/nuvasive-inc.

On September 19, 2017, GlassHouse Research accused the Company of “accounting irregularities” involving “channel stuffing,” pulling forward of future revenue, and delaying normalized expenses based on the Company’s accrued expenses.

On this news, the Company’s share price 7.3% on September 19, 2017, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/GPM_LLP.

If you purchased NuVasive securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los Angeles/New York
Lesley Portnoy, 310-201-9150 or 888-773-9224
[email protected]
www.glancylaw.com